FDA orders review of jaw joint implants
The Food and Drug Administration has ordered a review of the performance of artificial jaw joint implants after finding a substantial number of problems with the products in recent years. The action comes a couple months after a Journal Sentinel investigation found that the agency had approved four such devices beginning in 1999, despite weak and incomplete research clouded by potential conflicts of interest. In announcing the action, the agency said it found a substantial number of adverse events involving the devices between 2004 and 2010, including patients who had to have devices removed prematurely after they were implanted because of extreme pain. Many of those patients were forced to undergo surgery to remove the devices in less than three years. That is considerably shorter than the expected five-year minimum, the agency said.
- As Retail Clinics Surge, Quality Metrics MIA
- Providers' Push to Consolidate Roils Payers
- Medicare Cost, Quality Data Tools Weak, Says GAO
- No Employee Satisfaction, No Patient-Centered Culture
- RN Named Chief Patient Experience Officer
- Former NQF Co-Chair Linked to Conflicts of Interest in Journal Probe
- Population Health Pays Off for NY Collaborative
- How Simple Data Analytics is Driving Physician Incentives
- AMA Pushes Lame Duck Congress for SGR Repeal
- In PCMH, the 'P' is Not for 'Physician'